Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $190.30 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $54.86 | 4 | $0 (2019) |
| United Therapeutics Corporation | $48.46 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $35.93 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $13.65 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $13.01 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $12.41 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11.98 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $92.26 | 7 | Janssen Pharmaceuticals, Inc ($54.86) |
| 2018 | $17.43 | 1 | GlaxoSmithKline, LLC. ($17.43) |
| 2017 | $80.61 | 4 | United Therapeutics Corporation ($48.46) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/26/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/29/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.01 | General |
| 03/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: RESPIRATORY | ||||||
| 12/22/2017 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PAH | ||||||
| 09/15/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2017 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: PAH | ||||||
| 07/14/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: Cardiovascular | ||||||
About Dr. Culpepper Mcculler, MD
Dr. Culpepper Mcculler, MD is a Pulmonary Disease healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275577629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Culpepper Mcculler, MD has received a total of $190.30 in payments from pharmaceutical and medical device companies, with $92.26 received in 2019. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($190.30).
Practice Information
- Specialty Pulmonary Disease
- Location Shreveport, LA
- Active Since 06/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1275577629
Products in Payments
- XARELTO (Drug) $54.86
- ORENITRAM (Drug) $48.46
- NUCALA (Biological) $35.93
- ELIQUIS (Drug) $13.65
- ZERBAXA (Drug) $12.41
- SPIRIVA RESPIMAT (Drug) $11.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Shreveport
Dr. Kirit Patel, M.d, M.D
Pulmonary Disease — Payments: $113,159
Ammar Alqaid, Md, MD
Pulmonary Disease — Payments: $16,562
Ashley Ferraro, Do, DO
Pulmonary Disease — Payments: $3,130
Sukhmani Boparai, Md, MD
Pulmonary Disease — Payments: $2,297
Kimberly Jones, M.d, M.D
Pulmonary Disease — Payments: $1,715
Indira Sastry, M.d, M.D
Pulmonary Disease — Payments: $1,235